Lee D. Flowers - 19 Jul 2021 Form 3 Insider Report for HCW Biologics Inc. (HCWB)

Role
SVP of Business Development
Signature
/s/ Hing C. Wong, as Attorney-in-Fact for Lee D. Flowers
Issuer symbol
HCWB
Transactions as of
19 Jul 2021
Net transactions value
$0
Form type
3
Filing time
19 Jul 2021, 16:57:04 UTC
Next filing
23 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCWB Common Stock 36,427 19 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HCWB Stock Option (Right to Buy) 19 Jul 2021 Common Stock 17,142 $0.1400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These option shares were part of a stock option grant covering 21,427 shares of common stock. 20% of the total shares subject to the stock option grant vested on September 16, 2020; 20% of the total shares subject to the stock option grant will vest on September 16, 2021; 25% of the total shares subject to the stock option grant will vest on September 16, 2022; and 35% of the total shares subject to the stock option grant will vest on September 16, 2023.

Remarks:

Exhibit 24.1: Power of Attorney